WILLIAM CHASE

Insider Reports History

Location
Menlo Park, CA
Signature
/s/Donald Lang, as Attorney-in-Fact for William Chase
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by WILLIAM CHASE:

Company Role Class Num Shares Value Price $ Report Date Ownership
GRAIL, Inc. Director Common Stock 36,590 $2,763,276 $75.52 15 Oct 2025 Direct
Intellia Therapeutics, Inc. Director Common Stock 134,693 $1,350,970 $10.03 20 Aug 2025 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11,450 11 Jun 2025 Direct

Insider Reports Filed by WILLIAM CHASE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GRAL GRAIL, Inc. 15 Oct 2025 1 +$20,768 4 Director 16 Oct 2025, 18:17
NTLA Intellia Therapeutics, Inc. 20 Aug 2025 1 +$1,003,000 4 Director 22 Aug 2025, 16:30
GRAL GRAIL, Inc. 15 Jul 2025 1 +$20,536 4 Director 17 Jul 2025, 17:47
NTLA Intellia Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:25
GRAL GRAIL, Inc. 29 May 2025 1 +$249,970 4 Director 30 May 2025, 19:23
GRAL GRAIL, Inc. 15 Apr 2025 1 +$20,337 4 Director 16 Apr 2025, 18:34
GRAL GRAIL, Inc. 15 Jan 2025 1 +$20,780 4 Director 16 Jan 2025, 16:53
GRAL GRAIL, Inc. 30 Oct 2024 1 +$2,860 4 Director 01 Nov 2024, 18:17
GRAL GRAIL, Inc. 15 Oct 2024 1 +$14,767 4 Director 17 Oct 2024, 18:33
GRAL GRAIL, Inc. 25 Jun 2024 1 $0 4 Director 27 Jun 2024, 17:14
NTLA Intellia Therapeutics, Inc. 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:16
GRAL GRAIL, LLC 11 Jun 2024 0 $0 3 Director 11 Jun 2024, 19:25
NTLA Intellia Therapeutics, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:30
NTLA Intellia Therapeutics, Inc. 14 Apr 2023 2 $0 4 Director 18 Apr 2023, 17:04
NTLA Intellia Therapeutics, Inc. 14 Apr 2023 0 $0 3 Director 18 Apr 2023, 16:49